On the other hand, studies of intestinal inflammation in murine models have reported that IL-33 itself can play a beneficial or harmful role in IBD depending on the induction of mucosal damage (acute or chronic) or the colitogenic used, arguing against a precise role of the IL-33/ST2 axis. Here, IL33 is linked to inflammatory bowel disease.